Biotech & pharma
New drug could cure nearly any viral infection
By By Anne Trafton, MIT News Office | 10 Aug 2011
Researchers at MIT’s Lincoln Lab have developed technology that may someday cure the common cold, influenza and other ailments.
Potential new eye tumour treatment discovered
08 Aug 2011
Brain training increases dopamine release
06 Aug 2011
Disease-causing tangle could spawn new materials
01 Aug 2011
Beefing up muscles can reduce diabetes risk
29 Jul 2011
Now, gastric bypass surgery to shed weight
27 Jul 2011
A growing number of obese patients are choosing to undergo bariatric surgery in order to lose weight
Are cancers newly evolved species?
27 Jul 2011
Tumour cells go against the flow
By By Alissa Mallinson, Mechanical Engineering | 23 Jul 2011
Microfluidic model helps explain how fluid’s flow in bodily tissue influences tumour cell migration.
Mapping of 'sixth nucleotide' in embryonic stem cells indicates it may activate genes
By By Kim Irwin | 23 Jul 2011
The finding by researchers may prove to be important in controlling diseases like cancer, in which the regulation of certain genes plays a role in disease development.
New lung cancer gene found
20 Jul 2011
The biology behind alcohol-induced blackouts
20 Jul 2011
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
